Clinical Trials Directory

Trials / Unknown

UnknownNCT01763593

Safety and Surgical Performance Study of Aurosleek Surgical Blades

A Prospective, Open Label, Observational Study To Evaluate The Safety And Surgical Performance Of Surgical Blade (Aurosleek) In Cataract Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
35 (estimated)
Sponsor
Aurolab · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To evaluate the safety and surgical effectiveness of surgical blades (Aurosleek) made by Aurolab.

Detailed description

Cataract till today remains the most common yet treatable cause of blindness accounting for more than 50% of blindness and visual impairment in the developing world. One of the most important features of a blade for cataract surgery is its predictable and repeatable behavior. The surgeon repeatedly and reliably needs to create similar tunnels of the proper length. Aurolab is producing surgical blades (Aurosleek) intended for making incision in cataract surgeries.

Conditions

Timeline

Start date
2013-03-01
Primary completion
2013-05-01
Completion
2013-06-01
First posted
2013-01-09
Last updated
2013-04-30

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT01763593. Inclusion in this directory is not an endorsement.

Safety and Surgical Performance Study of Aurosleek Surgical Blades (NCT01763593) · Clinical Trials Directory